ArticleThe Lancet. Oncology2022
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.
Tomer Meirson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it
ArticleThe Lancet. Oncology2022
Tomer Meirson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.